Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/BS.IRCMB.2020.01.004 | ||||
| Año | 2020 | ||||
| Tipo | revisión |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Stressors elicit a neuroendocrine response leading to increased levels of glucocorticoids, allowing the organism to adapt to environmental changes and maintain homeostasis. Glucocorticoids have a broad effect in the body, modifying the activity of the immune system, metabolism, and behavior through the activation of receptors in the limbic system. Chronic exposition to stressors operates as a risk factor for psychiatric diseases such as depression and posttraumatic stress disorder. Among the cellular alterations observed as a consequence of environmental stress, alterations to organelle function at the level of mitochondria and endoplasmic reticulum (ER) are emerging as possible factors contributing to neuronal dysfunction. ER proteostasis alterations elicit the unfolded protein response (UPR), a conserved signaling network that re-establish protein homeostasis. In addition, in the context of brain function, the UPR has been associated to neurodevelopment, synaptic plasticity and neuronal connectivity. Recent studies suggest a role of the UPR in the adaptive behavior to stress, suggesting a mechanistic link between environmental and cellular stress. Here, we revise recent evidence supporting an evolutionary connection between the neuroendocrine system and the UPR to modulate behavioral adaptive responses.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Diaz-Hung, Mei-Li | - |
Universidad de Chile - Chile
Centro de Gerociencia, Salud Mental y Metabolismo - Chile |
| 2 | Martinez, Gabriela | Mujer |
Universidad de Chile - Chile
Centro de Gerociencia, Salud Mental y Metabolismo - Chile |
| 3 | HETZ-FLORES, CLAUDIO ANDRES | Hombre |
Universidad de Chile - Chile
Centro de Gerociencia, Salud Mental y Metabolismo - Chile Buck Inst Res Aging - Estados Unidos Buck Institute for Age Research - Estados Unidos Buck Institute for Research on Aging - Estados Unidos |
| 4 | Kepp, O | - | |
| 5 | Galluzzi, L | - |
| Fuente |
|---|
| FONDECYT |
| Fondef |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Fondo de Fomento al Desarrollo Científico y Tecnológico |
| Millennium Institute |
| Air Force Office of Scientific Research |
| Muscular Dystrophy Association |
| Fondo Nacional de Desarrollo CientÃfico y Tecnológico |
| FONDAP program |
| ALSRP Therapeutic Idea Award |
| European Commission RD MSCA-RISE |
| U.S. Air Force Office of Scientific Research |
| Fondo de Fomento al Desarrollo CientÃfico y Tecnológico |
| Michael J. Fox Foundation for Parkinson's Research |
| CONICYT-Brazil |
| European Commission R&D |
| Michael J Fox Foundation for Parkinson's Research-Target Validation grant |
| Michael J Fox Foundation |
| ECOS CONICYT |
| ECOS CONICYT Cooperation grant Chile-France |
| Millennium Institute P09-015-F |
| Agradecimiento |
|---|
| This work was funded by Fondecyt 3190596 (MLD), FONDECYT 1180186, FONDAP program 15150012, ECOS CONICYT Cooperation grant Chile-France ECOS170032 (HU, CH), Millennium Institute P09-015-F and European Commission R&D MSCA-RISE 734749 (CH). We also thank the support from Michael J Fox Foundation for Parkinson's Research-Target Validation grant 9277, FONDEF ID16I10223, FONDEF D11E1007, U.S. Air Force Office of Scientific Research FA9550-16-1-0384, ALSRP Therapeutic Idea Award AL150111, Muscular Dystrophy Association 382453, and CONICYT-Brazil 441921/2016-7 (CH). |
| This work was funded by Fondecyt 3190596 (MLD), FONDECYT 1180186, FONDAP program 15150012, ECOS CONICYT Cooperation grant Chile-France ECOS170032 (HU, CH), Millennium Institute P09-015-F and European Commission R&D MSCA-RISE 734749 (CH). We also thank the support from Michael J Fox Foundation for Parkinson's Research—Target Validation grant 9277, FONDEF ID16I10223, FONDEF D11E1007, U.S. Air Force Office of Scientific Research FA9550-16-1-0384, ALSRP Therapeutic Idea Award AL150111, Muscular Dystrophy Association 382453, and CONICYT-Brazil 441921/2016-7 (CH). |